The PSA Screening for HIM Act was introduced in the U.S. House of Representatives on March 28, 2023. This bipartisan legislative proposal would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease.
RALEIGH, NC – March 27, 2022 – Today, Gov.
HARRISBURG, PA – MARCH 28, 2023 – At the start of Colorectal Cancer (CRC) Awareness Month, the American Cancer Society (ACS) released their report “Colorectal Cancer Facts & Figures 2023-2025,” which found that colorectal cancer is rapidly shifting to more advanced disease and younger individ
CONDADO DE DUTCHESS, NY – 28 DE MARZO DE 2023 – Al comienzo del Mes de Concientización sobre el Cáncer Colorrectal (CCR, por sus siglas en inglés), la Sociedad Americana Contra el Cáncer (ACS) publicó su informe "Datos y estadísticas sobre el cáncer colorrectal 2023-2025", que en
Allie Kast was recently promoted to government relations director for the American Cancer Society Cancer Action Network (ACS CAN). In this role, Kast will lead ACS CAN’s efforts in the state to advance legislation and public policies to reduce cancer.
Rhode Island lawmakers have taken the first step towards ensuring cancer patients and others with chronic disease are protected from excessive prescription drug costs.
ANNAPOLIS, MD – MARCH 27, 2023 – Lance Kilpatrick has joined the American Cancer Society Cancer Action Network (ACS CAN) as the Government Relations Director in Maryland, Delaware and Washington, D.C.
The following originally appeared in the Asbury Park Press on March 24, 2023.
RALEIGH, NC – March 23, 2022 – On the 13th anniversary of the Affordable Care Act, the North Carolina legislature today – in a 87-24 vote – voted to expand Medicaid, making North Carolina the 40th state to i
The American Cancer Society Cancer Action Network (ACS CAN) applauds members of the New Mexico State Legislature for passing House Bill 73 as the 2023 legislative session wrapped up. With the signature of Governor Michelle Lujan Grisham, the bill will expand access to biomarker testing statewide, helping to revolutionize cancer care in New Mexico.